Personal Patient Profile-Prostate: Testing and Implementation in Health Networks

描述（由申请人提供）：P3 P是第一个针对局限性前列腺癌（LPC）男性的自动化和定制干预，以证明在美国样本中的疗效。我们有证据表明，P3 P减少了决策冲突;用他们的话说，男人能够“为我选择最好的治疗方法。“然而，与许多决策支持技术和干预措施一样，部署作为癌症临床护理的一个组成部分尚未建立，特别是在常规实践和成本的可行性方面。LPC可以用一种或多种方式治疗，包括单独观察、手术、冷冻手术、激素治疗、近距离放射治疗或外部射束放射治疗。在北美环境中，这些治疗方式的随机研究很少有充分比较性，膀胱和肠道功能障碍并发症的结果。在未来的许多年里，男性将听到临床医生的建议，但也将被要求对前列腺癌治疗做出重大选择。这些决定可以极大地改变男人的生活。这项混合有效性-实施研究的目的是在地理、种族和种族多样化的医疗保健环境中部署和评价一种有效的、以患者为中心的治疗决策技术，作为支持新诊断LPC男性的一种手段。我们将收集与使用P3 P计划与标准实践准备治疗决策相关的资源成本。将在三个健康网络环境中收集与P3 P实施可行性相关的数据，这些健康网络环境为不同的前列腺癌男性人群提供服务。

DESCRIPTION (provided by applicant): The P3P is the first automated and tailored intervention for men with localized prostate cancer (LPC) to demonstrate efficacy in a U.S. sample. We have evidence that the P3P decreases decisional conflict; men are able to, in their words, "choose the best treatment for me." Yet as with many decision support technologies and interventions, deployment as an integral component of cancer clinical care has not been established, notably with regard to feasibility as routine practice and to costs. LPC can be treated with one or more modalities including observation alone, surgery, cryosurgery, hormonal therapy, brachytherapy, or external beam radiation therapy. There are few findings from randomized studies of these treatment modalities in North American settings that adequately compare the complications of sexual, bladder, and bowel dysfunction. For many years to come, men will hear clinician recommendations but also will be asked to make major choices about prostate cancer treatments. These decisions can dramatically change men's lives. The purpose of this hybrid effectiveness-implementation study is to deploy and evaluate an efficacious, patient-centered, treatment decision technology in geographically, ethnically and racially diverse health care settings as a means to support men with newly diagnosed LPC. We will collect resource costs associated with preparation for the treatment decision using the P3P program versus standard practice. Metrics associated with viability of P3P implementation will be collected in each of three health network settings which serve a diverse population of men with prostate cancer.